Ironwood Capital
Signal active
Investment Firm
Overview
Ironwood Capital is a private equity firm that provides non-control growth capital solutions to middle-market businesses.
The firm invests in the form of subordinated debt and preferred stock in amounts ranging from $5 million to $20 million to support business owners and financial sponsors in growth financings, full and partial recapitalizations, generational transitions, and buyouts.
Ironwood Capital was founded in 1985 and is based in Avon, Connecticut.
Highlights
Founded
1985
Industry
Financial Services
Employees
11-50
Investment
33
Lead Investment
7
Exits
12
Stages
Seed, Private Equity, Early Stage Venture, Late Stage Venture
Investor Type
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
Ironwood Capital, established in 1985 and headquartered in United States, North America., specializes in Seed, Private Equity, Early Stage Venture, Late Stage Venture investments across Software, Health Care, Fitness, Wellness, Information Technology, Financial Services, Telecommunications, Enterprise, B2B, Mobile Advertising. The organization boasts a portfolio of 33 investments, with an average round size of $8.5M and 12 successful exits. Their recent investments include FitLinxx, North Atlantic Capital, Floop, Advantage Capital, NovaTract Surgical. The highest investment round they participated in was $10.3B. Among their most notable exits are FitLinxx and North Atlantic Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Ironwood Capital has made 33 investments. Their most recent investment was on Oct 16, 2023, when Modifi Bio raised $4.3M.
Ironwood Capital has made 7 diversity investments. Their most recent diversity investment was on Jan 09, 2020, when IsoPlexis raised $20.0M.
investments
33
Diversity investments
7
Lead investments
7
Number of exits
12
Investments
33
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 28, 2022 | Modifi Bio | Biotechnology | 6.4M |
| Nov 16, 2022 | - | - | 13.0M |
| Jan 05, 2023 | - | - | null |
| Oct 16, 2023 | Modifi Bio | Biotechnology | 4.3M |
Exits
12
Funding Timeline
Funding rounds
33
Investors
0
Funds
3
Funding Rounds
33
Ironwood Capital has raised 33 rounds. Their latest funding was raised on Oct 16, 2023 from a Seed Round - Modifi Bio round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 28, 2022 | Seed Round - Modifi Bio | - | 6.4M | - |
| Nov 16, 2022 | Series A - Torigen Pharmaceuticals | - | 13.0M | - |
| Jan 05, 2023 | Private Equity Round - Le Sueur Incorporated | - | 0 | - |
| Oct 16, 2023 | Seed Round - Modifi Bio | - | 4.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.